Atom Grants
Discover

    Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.

    Overview
    Eligibility
    Sources (1)
    Similar Grants
    Researchers

    Funder: Food and Drug Administration (FDA)

    Due Dates: Projected July 2025

    Funding Amounts: Up to $400,000 per award; typical duration not specified

    Summary: Supports innovative natural history studies to accelerate medical product development for rare diseases with unmet needs.

    Key Information: Forecasted opportunity; all dates and details are subject to change.


    Description

    This opportunity supports efficient and innovative natural history studies focused on rare diseases or conditions with unmet medical needs. The goal is to generate high-quality, interpretable data that address critical knowledge gaps, remove barriers to progress, and broadly impact the development of medical products for rare diseases. Projects may target a single rare disease or multiple related diseases with similar pathophysiology. The program encourages studies that will facilitate the development and evaluation of new therapies, diagnostics, or interventions in the rare disease space.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.